EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Resistance to novel antimicrobial agents among NDM-and OXA-48-producing Carbapenem-resistant Enterobacterales in Lebanon

George F Araj, Joseph M Matar, Chaza K Al Ghor, Ghena M Sobh, Clara R Dagher

Frontiers in Cellular and Infection Microbiology · 2026

DOI: 10.3389/fcimb.2026.1938955 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von George F Araj und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Microbiology Laboratory, Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon. Hauptthemen laut MEDLINE: beta-Lactamases, Carbapenem-Resistant Enterobacteriaceae, Escherichia coli, Anti-Bacterial Agents. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rapid detection of carbapenemases and antimicrobial susceptibility testing (AMST) against carbapenem-resistant (CR) Enterobacterales (CRE) are key elements in controlling their nosocomial spread and useful to guide treatment of patients infected with such morbid pathogens. The absence of comprehensive data in Lebanon prompted this study.

Objective

This study aimed at revealing the carbapenemase types among CR isolates recovered from patients representing 100 Escherichia coli (CREc) and 40 Klebsiella pneumoniae (CRKp). Their antimicrobial resistance (AMR) profiles against routine and novel antimicrobial agents were also determined.

Methods

Identification of isolates was done by MALDI-TOF, and the types of carbapenemases were determined by the rapid NG-Test CARBA. Antimicrobial resistance (AMR) profiles were revealed against the routine antibiotics, including ceftazidime-avibactam, and novel antimicrobial agents that still have not been introduced in this country, namely, imipenem-relebactam, meropenem-vaborbactam, and cefiderocol using disk diffusion and standard Etest methods.

Results

Among both CREc and CRKp, the detected carbapenemases were only NDM and OXA-48, whereby the majority were NDM. The activity of novel antimicrobial agents was higher against CREc than CRKp isolates, and against OXA-48- producing strains than NDM-producing strains in both species.

Conclusion

This first comprehensive in vitro study from Lebanon revealed high resistance (28%-100%, and 0%-100% among NDM and OXA-48 producers, respectively) of yet-to-be- introduced novel antimicrobial agents in this country. This highlights the necessity of scrutinizing the proper use of antimicrobial agents, stewardship programs, and infection control aspects to curb the morbid impact of these pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesCarbapenem-Resistant EnterobacteriaceaeEscherichia coliAnti-Bacterial AgentsKlebsiella pneumoniaeBacterial ProteinsLebanonHumansMicrobial Sensitivity TestsThird Generation CephalosporinsCefiderocolCarbapenemsDrug Resistance, Multiple, BacterialCeftazidimeAzabicyclo CompoundsKlebsiella InfectionsEnterobacteriaceae InfectionsEscherichia coli InfectionsDrug CombinationsSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Stichwörter der Autor:innen

NG-Test CARBA-5Novel antibioticsantimicrobial resistancecarbapenem- resistant Enterobacteralescarbapenemases

Substanzen

beta-LactamasesAnti-Bacterial AgentsBacterial ProteinscarbapenemaseThird Generation CephalosporinsCefiderocolCarbapenemsCeftazidimeAzabicyclo Compoundsavibactam, ceftazidime drug combination

Autor:innen und Institutionen

  • Clinical Microbiology Laboratory, Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
  • Center for Infectious Diseases Research, American University of Beirut Medical Center, Beirut, Lebanon.
  • Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

Zitieren

APA

Araj, G. F., Matar, J. M., Al Ghor, C. K., Sobh, G. M., & Dagher, C. R. (2026). Resistance to novel antimicrobial agents among NDM-and OXA-48-producing Carbapenem-resistant Enterobacterales in Lebanon. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1938955

Vancouver

Araj GF, Matar JM, Al Ghor CK, Sobh GM, Dagher CR. Resistance to novel antimicrobial agents among NDM-and OXA-48-producing Carbapenem-resistant Enterobacterales in Lebanon. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1938955

BibTeX
@article{Araj2026,
  author = {Araj, George F and Matar, Joseph M and Al Ghor, Chaza K and Sobh, Ghena M and Dagher, Clara R},
  title = {Resistance to novel antimicrobial agents among NDM-and OXA-48-producing Carbapenem-resistant Enterobacterales in Lebanon},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  doi = {10.3389/fcimb.2026.1938955}
}
Kostenlos starten →